A Phase II Randomized Study of the Virologic and Immunologic Effect of Zidovudine + Stavudine versus Stavudine Alone and Zidovudine + Lamivudine in Patients with >300 CD4 Cells Who Were Antiretroviral Naive (ACTG 298)-Reference-Cited by-同舟云学术

A Phase II Randomized Study of the Virologic and Immunologic Effect of Zidovudine + Stavudine versus Stavudine Alone and Zidovudine + Lamivudine in Patients with >300 CD4 Cells Who Were Antiretroviral Naive (ACTG 298)

Published:2002-07 Issue:10 Volume:18 Page:699-704
ISSN:0889-2229
Container-title:AIDS Research and Human Retroviruses
language:en
Short-container-title:AIDS Research and Human Retroviruses

Author:

Pollard Richard B.¹,Tierney Camlin²,Havlir Diane³,Tebas Pablo⁴,Fox Lawrence⁵,Smeaton Laura²,Richman Douglas⁶,Friedland Gerald H.⁷

Affiliation:

1. University of California, Davis Medical Center, Sacramento, California 95817

2. Harvard School of Public Health, Cambridge, Massachusetts 02115

3. University of California, San Diego, California 92103

4. Washington University School of Medicine, St. Louis, Missouri 63110

5. Division of AIDS, National Institutes of Health, Bethesda, Maryland 20892

6. University of California, San Diego, California 92103, and San Diego VA Medical Center, San Diego, California 92103

7. Yale School of Medicine, New Haven, Connecticut 06510

Publisher

Mary Ann Liebert Inc

Subject

Infectious Diseases,Virology,Immunology

Link

http://www.liebertpub.com/doi/pdf/10.1089/088922202760072311

Reference11 articles.

1. Biologic Effects And Safety Of Stavudine: Overview Of Phase I And Ii Clinical Trials

2. Treatment with Lamivudine, Zidovudine, or Both in HIV-Positive Patients with 200 to 500 CD4+ Cells per Cubic Millimeter

3. In Vivo Antagonism with Zidovudine plus Stavudine Combination Therapy

4. Lamivudine or Stavudine in Two- and Three-Drug Combinations against Human Immunodeficiency Virus Type 1 Replication In Vitro

5. Evaluation of the Combination Effect of Different Antiviral Compounds against HIV in Vitro

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. InforMatrix nucleoside/nucleotide reverse transcriptase inhibitor ‘backbones’;Expert Opinion on Pharmacotherapy;2007-10

2. Predictors of Residual Viremia in HIV‐Infected Patients Successfully Treated with Efavirenz and Lamivudine plus either Tenofovir or Stavudine;The Journal of Infectious Diseases;2005-04

3. Determining the antiviral activity of tenofovir disoproxil fumarate in treatment-naive chronically HIV-1-infected individuals;AIDS;2003-05

4. Cellular Pharmacology of D-d4FC, a Nucleoside Analogue Active against Drug-Resistant HIV;Antiviral Chemistry and Chemotherapy;2003-02